Search
Biotech entrepreneurs share advice on navigating through today's uncertain times: "It's going to be okay"
MassBio CEO Kendalle Burlin O'Connell moderates a discussion with Normunity CEO Rachel Humphrey and Gallop Oncology CEO Luba Greenwood about how they are rising to today's challenges. Topics include the funding environment, motivating your team, storytelling, FDA engagement, and perseverance. Chapters Intro's – 0:52 The funding environment - 2:51 Motivating your team – 17:20 Storytelling – 28:17 Engagement with FDA – 39:51 Perseverance – 42:23 Advice for new entrepreneurs – 4
Oct 21
MassBio's CEO Kendalle Burlin O'Connell shares the details of today's just published 2025 Industry Snapshot - a key barometer of the health of biotech not just in Massachusetts, but as an industry
She discusses the report and specifics on NIH funding, VC investment, jobs, biotech clusters within Massachusetts, and more. VIEW THE...
Aug 26
Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science
In this inaugural episode of Biotech Direct, BiotechTV's new show that will share the biotech industry's perspective on policy and...
Aug 15
MassBio's CEO on the Align Summit and supporting the innovation ecosystem in Massachusetts
Kendalle Burlin O'Connell describes the goals of the Align Summit and the work MassBio is doing.
Apr 25, 2024
.png){kind=logo}
